The Production-Linked Incentive (PLI) scheme for pharmaceutical sector was launched with the objective of enhancing India’s manufacturing capabilities by increasing investment and contributing to product diversification. The Scheme would largely promote development of complex and high tech products, production of high value products and employment for both skilled and unskilled labour.
An incentive of INR 15,000 crore has been planned, which will be implemented over 9-year period starting from 2020-21. To know more on the scheme and its impact, Grant Thornton Bharat invites you to a webinar on Production Linked Incentive scheme for Pharma Sector.
Key discussion points:
- Overall PLI Scheme capturing Government objective, scheme coverage and corresponding incentives
- Who is eligible for the scheme
- Application and disbursement process
- What are the incentives involved
- How can Grant Thornton Bharat assist
